Navigation Links
Medifast Announces Opening of First Franchise Clinic
Date:10/8/2008

Company Continues to See Strength in Overall Business Trends in Difficult

Economic Environment

OWINGS MILLS, Md., Oct. 8 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED) announced the opening of the first franchisee-owned Medifast Weight Control Center in the Baltimore, Maryland market located at 5 Bel Air S. Parkway, Bel Air, MD 21015 in the Festival at Bel Air Shopping Center. This marks a milestone for the company as it continues to expand the brick-and-mortar clinic model throughout the United States using a combination of both corporate and franchisee-owned clinics. The first clinic opening in the Baltimore market is part of the previously announced sale of four franchise rights agreements in this market. The franchisee also has the right to open four additional Medifast Weight Control Centers in the Baltimore area over the next two years, bringing the total to eight locations.

In addition to the recently opened franchise clinic, the company currently operates 20 corporate-owned clinics including 10 in Dallas, eight in Houston and two in the Orlando market. The company continues to seek opportunities to expand its reach throughout the United States in both corporate- and franchisee-owned clinics with an additional five clinics expected to open through the end of the year.

"We are pleased to announce the opening of our first franchisee-owned Medifast Weight Control Centers," commented Mr. Michael S. McDevitt, Chief Executive Officer of Medifast. "We believe this is a significant step in geographically expanding the awareness of the clinically proven Medifast weight loss program and the extensive support channels that we provide to help customers successfully achieve their weight loss
'/>"/>

SOURCE Medifast, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Medifast Announces Winners of Mother-Daughter Challenge
2. Medifast, Inc. Announces Support for Microsoft HealthVault
3. Medifast Announces Updated Full Year 2007 Guidance
4. Medifast Announces Third-Quarter 2007 Results
5. Medifast, Inc. Receives Approval to Sell Medifast Weight Control Centers Franchises in Seven Additional States
6. Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008
7. Medifast, Inc. Director of Research & Development Co-Authors Health Book
8. Medifast Receives Notice Regarding NYSE Listing
9. Medifast Offers Stranded Pure Weight Loss Clients Unique Options
10. Medifast Offers 5 Heart Healthy Tips in Recognition of Fridays National Wear Red Day
11. Medifast Franchise Systems Sells First Territory in Baltimore
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6Health News:Buffalo Personal Injury Lawyers Cellino & Barnes Donate $1M to UB School of Law, Appear on Cover of School's Philanthropy Magazine 2Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:The Flag Company, Inc.'s Recently Released “Feel Good” Light Lenses Grows Into Its Own Website 2Health News:The Flag Company, Inc.'s Recently Released “Feel Good” Light Lenses Grows Into Its Own Website 3Health News:NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus 2
Breaking Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Mathematical modeling predicts response to Herceptin 52980 1Mathematical modeling predicts response to Herceptin 52980 2Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 1Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 2Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 3Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 4The CLASS Act 3A Retirement In Security 52977 1The CLASS Act 3A Retirement In Security 52977 2